Cd4+ Lymphocyte Deficiency: Clinical Trials

1 trial for Cd4+ Lymphocyte Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1

Follow Cd4+ Lymphocyte Deficiency: new trials by email Literature Review of Cd4+ Lymphocyte Deficiency trials Research Report on Cd4+ Lymphocyte Deficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia
FT538, Vorinostat - HIV-1-infection, ART
Phase 1WithdrawnMasonic Cancer Center, University of Minnesota2024-07-152024-02-26

Narrower conditions

Acquired Immunodeficiency Syndrome (1)  ·  Infections (1)

Broader conditions

Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Lentivirus Infections (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Sexually Transmitted Diseases (1)  ·  Sexually Transmitted Diseases, Viral (1)  ·  Slow Virus Diseases (1)  ·  Urogenital Diseases (1)  ·  Virus Diseases (1)

Interventions

Vorinostat (1)

Sponsors

Masonic Cancer Center, University of Minnesota (1)

Countries

United States (1)